SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-056571
Filing Date
2019-10-25
Accepted
2019-10-25 17:02:51
Documents
2
Period of Report
2019-10-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1920815d1_8k.htm 8-K 17869
2 EXHIBIT 10.1 tm1920815d1_ex10-1.htm EX-10.1 39178
  Complete submission text file 0001104659-19-056571.txt   58462
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 (973) 242-0005
Neurotrope, Inc. (Filer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38045 | Film No.: 191170580
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences